BIG WIN FOR ENDOMETRIAL CANCER PATIENTS AND RESEARCH AT CARILION

A new medication is now available for treating endometrial cancer patients, and our researchers in Gynecology Oncology contributed to the work. Carilion is one of 164 sites in the U.S., Europe, and Canada that enrolled patients and collected data that led to the recent FDA approval of Dostarlimab, also known as Jemperli. Learn more about our cancer clinical trials here. 

R&D would like to thank our incredible PI, Dr. David Iglesias, as well as our dedicated sub-investigators, Drs. Shannon Armbruster, Janet Osborne, and Erin Saks and Meredith Friend. We would also like to thank the pharmacy team, clinic nurses, and infusion nurses for the crucial role they play in every one of our clinical trials. Finally, and arguably most importantly, we would like to thank our team of Clinical Research Coordinators (Jessica Nichols, Christopher Hinton, Jared Gordon, and Sophie Corazza) for their tireless effort and dedication to the success of our Oncology Research Program. Together, we are making a difference in the lives of cancer patients and their families.